Melody Holmes is hoping her Givealittle crowd funding page will help towards the $100,000 cost of getting stem cell treatment in Russia. “For someone staring into the darkness of a future of pain and disability, that’s an amazing light of hope,” writes Melody Holmes on her Givealittle crowd funding page. She’s talking about the chance to go...
Tag: <span>Multiple sclerosis</span>
Game-Changing Stem Cell Treatment Gives Multiple Sclerosis Patients Hope
Stem cell transplants may be the answer to multiple sclerosis. A new study found that haematopoietic stem cell transplantation was highly successful in diminishing the symptoms of multiple sclerosis patients. ( Spencer Platt | Getty Images ) Thanks to stem cell treatment, it might be possible to stop multiple sclerosis and improve its symptoms. A potentially disabling disease of the...
Stem cell transplants are a ‘game changer’ for MS patients: Trial shows the pioneering method can stop the debilitating disease in its tracks
More than 100 patients with a common form of MS were involved in the study They were either given a stem cell transplant or were given conventional drugs The £30,000 treatment involves flooding the immune system with cancer drugs The immune system is then rebooted with stem cells from the MS patient’s blood Stem cell...
Siponimod cuts risk of disability progression in multiple sclerosis
(HealthDay)—For patients with secondary progressive multiple sclerosis, the selective sphingosine 1-phosphate (S1P) receptor1,5 modulator, siponimod, is associated with reduced relative risk of confirmed disability progression, according to a study published online March 22 in The Lancet. Ludwig Kappos, M.D., from the University of Basel in Switzerland, and colleagues conducted a phase 3 trial at 292 hospital clinics...
Multiple sclerosis sufferer says she was CURED of her symptoms after losing 100 pounds
Marleen Wardalazarr was diagnosed with multiple sclerosis in February 2015 She did research and decided to change her lifestyle to help with symptoms Even though she was taking drugs she was still experiencing dizziness, loss of mobility, and lack of ability to swallow food or water The 26-year-old now has lost 100 pounds and said...
Over-the-counter lipoic acid may slow the progression of multiple sclerosis, study finds
Lipoic acid reduced brain shrinkage in patients with secondary progressive MS Compared to a placebo, it improved atrophy by 68% Portland researchers found In comparison, FDA-approved drug ocrelizumab showed reduction of just 18% People with SPMS don’t recover from relapses and see a worsening of disability There’s no known cure for this or any type of...
More multiple sclerosis-causing mutations found in Canadian families
Carles Vilarino-Guell is an Assistant Professor of Medical Genetics, University of British Columbia. Less than a year after publishing research identifying a single genetic mutation that caused multiple sclerosis (MS) in two Canadian families, scientists at the University of British Columbia have found a combination of two other mutations in another family that made...
Multiple sclerosis: Novel immunotherapy reverses paralysis in mice
Researchers may be one step closer to developing new treatments for multiple sclerosis, after discovering a way to tame the erratic immune response that triggers the disease and reverse paralysis in mouse models of the disease. The picture on the left shows a paralyzed mouse model of MS prior to treatment. The picture on the...
New multiple sclerosis drug, backed by 40 years of research, could halt disease
An MRI scan of a person with multiple sclerosis shows bright spots, which are MS plaques. A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) – is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance...
Researchers make major brain repair discovery in fight against Multiple Sclerosis
Queen’s University Belfast scientists have discovered that specific cells from the immune system are key players in brain repair – a fundamental breakthrough that could revolutionise the treatment of debilitating neurological disorders such as Multiple Sclerosis (MS). The research study, led by Dr Yvonne Dombrowski and Dr Denise Fitzgerald at the Wellcome-Wolfson Institute for Experimental...